Please wait...

Valganciclovir Prescription
Generic Name: valganciclovir (val gan SYE kloe veer)
Brand Name: Valcyte
Physician reviewed valganciclovir patient information - includes valganciclovir description, dosage and directions.
  • Prescription Settings
  • X
  • medly Free, same-day prescription delivery to your doorstep is available in your area.
  • Learn more
  • Local Pharmacy Pickup available at . Pick up your medication at any of our participating pharmacies.
  • Mail Order Home Delivery available at , the easiest way to receive your medications.

Valganciclovir Coupons & Prices

Set your location
for drug prices near you

Enter your zip code

Please wait while the prices are loaded...
Click here to try again.

Don’t see your pharmacy listed? Most pharmacies accept our discounts, so have your pharmacist enter this coupon to see if you will save money:

Valganciclovir Drug Information:

ValGanciclovir is an antiviral drug. It works by preventing viral cells from multiplying in your body. ValGanciclovir is used in adults to prevent infection with cytomegalovirus (CMV) that may occur after an organ transplant (heart, kidney, or pancreas). ValGanciclovir is also used to treat CMV infection of the eye in adults with acquired immunodeficiency syndrome (AIDS). ValGanciclovir is used in children at least 4 months old to prevent CMV infection after a kidney transplant. ValGanciclovir is also used in children at least 1 month old to prevent CMV disease after a heart transplant. Learn more

Buy Valganciclovir Online and Valganciclovir Delivery

USARx offers the following ways to purchase this medication. Choose the Best option for you!

  • Guaranteed Price

    Local Pharmacy Pickup of Valganciclovir

    Pay this amount and pick up your prescription at ANY Retail pharmacy of your choice! Walgreens, CVS, Walmart, etc.

  • 30-day supply
    90-day supply

    Mail Order Home Delivery of Valganciclovir

    The easiest way to receive your medications.

Valganciclovir Side Effects

In Summary

Commonly reported side effects of valganciclovir include: anemia and neutropenia. Other side effects include: thrombocytopenia. See below for a comprehensive list of adverse effects.

For the Consumer

Applies to valganciclovir: oral powder for solution, oral tablet


Oral route (Tablet; Powder for Solution)

Severe leukopenia, neutropenia, anemia, thrombocytopenia, pancytopenia, bone marrow failure including aplastic anemia have been reported in patients treated with valganciclovir hydrochloride. Based on animal and limited human data, valganciclovir hydrochloride may cause temporary or permanent inhibition of spermatogenesis in males and suppression of fertility in females. Based on animal data, valganciclovir hydrochloride has the potential to cause birth defects in humans. Based on animal data, valganciclovir hydrochloride has the potential to cause cancers in humans.

Along with its needed effects, valganciclovir may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking valganciclovir:

More common

  • Black, tarry stools
  • blood in the urine or stools
  • blurred vision
  • chills
  • cough
  • dizziness
  • fever
  • headache
  • hoarseness
  • lower back or side pain
  • nervousness
  • painful or difficult urination
  • pale skin
  • pinpoint red spots on the skin
  • pounding in the ears
  • seeing flashes or sparks of light
  • seeing floating spots before the eyes
  • shakiness in the legs, arms, hands, or feet
  • shortness of breath
  • slow or fast heartbeat
  • sore throat
  • trembling or shaking of the hands or feet
  • troubled breathing
  • troubled breathing with exertion
  • ulcers, sores, or white spots in the mouth
  • unusual bleeding or bruising
  • unusual tiredness or weakness
  • veil or curtain appearing across part of vision

Less common

  • Changes in facial skin color
  • confusion
  • false beliefs
  • fast or irregular breathing
  • feeling, hearing, or seeing things that are not there
  • hives, itching, and skin rash
  • large, hive-like swellings on the eyelids, face, lips, mouth, or tongue
  • puffiness or swelling of the eyelids or around the eyes
  • runny or stuffy nose
  • seizures
  • tightness in the chest
  • trouble thinking

Some side effects of valganciclovir may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

  • Abdominal or stomach pain
  • diarrhea
  • headache
  • nausea and vomiting
  • numbness, tingling, pain, or weakness of the hands or feet
  • sleeplessness
  • tingling, burning, or prickly sensations
  • trouble with sleeping
  • unsteadiness or awkwardness

Less common

  • Agitation

For Healthcare Professionals

Applies to valganciclovir: oral powder for reconstitution, oral tablet


The most common adverse events in adults include diarrhea, pyrexia, fatigue, nausea, tremor, neutropenia, anemia, leukopenia, thrombocytopenia, headache, insomnia, urinary tract infection, and vomiting. The most common adverse events in pediatric patients include diarrhea, pyrexia, upper respiratory tract infection, urinary tract infection, vomiting, neutropenia, leukopenia, and headache.


Very common (10% or more): Diarrhea (up to 41%), nausea (up to 30%), vomiting (up to 21%), oral candidiasis (up to 20%), constipation (up to 20%), abdominal pain (up to 15%), dyspepsia (up to 12%)

Common (1% to 10%): Upper abdominal pain, abdominal distention, ascites, flatulence, dysphagia

Uncommon (0.1% to 1%): Mouth ulceration, pancreatitis


-Frequency not reported: Abdominal distension, ascites, cholangitis, dry mouth, dyspepsia, dysphagia, eructation, esophagitis, fecal incontinence, flatulence, gastritis, gastrointestinal disorder, gastrointestinal hemorrhage, mouth ulceration, pancreatitis, tongue disorder


Very common (10% or more): Anemia (up to 31%), neutropenia (including severe; up to 24%), thrombocytopenia (up to 22%), leukopenia (up to 20%)

Common (1% to 10%): Severe anemia, severe thrombocytopenia, severe leukopenia, pancytopenia (including severe)

Uncommon (0.1% to 1%): Bone marrow failure/depression

Rare (less than 0.1%): Aplastic anemia

Frequency not reported: Potentially life-threatening bleeding associated with thrombocytopenia, febrile neutropenia, neutrophil dysplasia with evidence of bone marrow hypoplasia


-Frequency not reported: Eosinophilia, leukocytosis, lymphadenopathy, splenomegaly

Neutropenia (absolute neutrophil count [ANC] less than 500/mcL: up to 19%; ANC 500 to less than 750/mcL: up to 17%; ANC 750 to less than 1000/mcL: up to 17%), anemia (hemoglobin [Hgb] less than 8 g/dL: up to 8%; Hgb less than 6.5 g/dL: up to 7%; Hgb 6.5 to less than 8 g/dL: up to 13%; Hgb 8 to less than 9.5 g/dL: up to 31%), and thrombocytopenia (less than 25,000 platelets/mcL: up to 4%; 25,000 to less than 50,000 platelets/mcL: up to 6%; 50,000 to less than 100,000 platelets/mcL: up to 22%) have been reported.

Severe neutropenia is more often seen in AIDS patients with CMV retinitis than in solid organ transplant patients.

Neutropenia has also been reported with a slightly higher incidence in 2 pediatric studies compared to adults, although neutropenia and infectious events were generally not correlated in the pediatric population.


Very common (10% or more): Pyrexia (up to 31%), lower limb edema (up to 21%), fatigue (up to 20%), peripheral edema (up to 18%), postoperative pain (up to 13%), postoperative complications (up to 12%), CMV infection (up to 12%), edema (up to 11%), postoperative wound infection (up to 11%)

Common (1% to 10%): Catheter-related infections, pain, weakness, sepsis (bacteremia, viremia), decreased weight, increased wound drainage, wound dehiscence, CMV syndrome, ear pain, chills, chest pain, malaise, asthenia

Frequency not reported: Local and systemic infections


-Frequency not reported: Asthenia, infections (bacterial, fungal, viral), malaise, mucous membrane disorder, pain, rigors, sepsis, decreased libido, edema, earache

Nervous system

Very common (10% or more): Tremors (up to 28%), headache (up to 22%)

Common (1% to 10%): Peripheral neuropathy, paresthesia, dizziness (excluding vertigo), dysgeusia, hypoesthesia, convulsion

Uncommon (0.1% to 1%): Deafness

Frequency not reported: Neurotoxicity


-Frequency not reported: Amnesia, ataxia, coma, hypertonia, myasthenic syndrome, migraine, myoclonic jerks, somnolence, tremor, taste disturbance, deafness, tinnitus


Very common (10% or more): Graft/transplant rejection (up to 24%)

Common (1% to 10%): Influenza, postoperative wound infection, pneumonia

Frequency not reported: Cellulitis, sepsis


Very common (10% or more): Insomnia (up to 20%)

Common (1% to 10%): Depression, anxiety, confusion, abnormal thinking

Uncommon (0.1% to 1%): Psychotic disorder, hallucinations, agitation


-Frequency not reported: Abnormal thinking, abnormal dreams, anxiety, decreased libido, emotional disturbance, hyperkinetic syndrome, nervousness


Very common (10% or more): Back pain (up to 20%)

Common (1% to 10%): Arthralgia, muscle cramps/spasms, limb pain, myalgia


-Frequency not reported: Musculoskeletal pain, increased blood creatine phosphokinase


Very common (10% or more): Urinary tract infection (up to 19%)

Common (1% to 10%): Dysuria, hematuria

Uncommon (0.1% to 1%): Male infertility

Postmarketing reports: Decreased fertility in males


-Frequency not reported: Hematuria present, impotence, urinary frequency


Very common (10% or more): Hypertension (up to 18%)

Common (1% to 10%): Hypotension, peripheral edema

Uncommon (0.1% to 1%): Arrhythmia


-Frequency not reported: Arrhythmia (including ventricular arrhythmia), deep thrombophlebitis, hemorrhage, hypertension, hypotension, phlebitis, tachycardia, vasodilatation


Very common (10% or more): Dermatitis (up to 18%)

Common (1% to 10%): Night sweats, pruritus, acne, cellulitis

Uncommon (0.1% to 1%): Alopecia, urticaria, dry skin


-Frequency not reported: Acne, alopecia, exfoliative dermatitis, dry skin, increased sweating, urticaria, photosensitivity reaction


Very common (10% or more): Elevated serum creatinine (up to 50%)

Common (1% to 10%): Renal impairment, decreased CrCl

Uncommon (0.1% to 1%): Renal failure

Frequency not reported: Acute renal failure


-Frequency not reported: Renal failure

Elevated serum creatinine (greater than 2.5 mg/dL: up to 17%; greater than 1.5 to 2.5 mg/dL: up to 50%) has been reported.


Very common (10% or more): Cough (up to 16%), pharyngitis/nasopharyngitis (up to 12%), dyspnea (up to 11%)

Common (1% to 10%): Productive cough, rhinorrhea, pleural effusion, sinusitis, upper respiratory tract infection, influenza, pneumonia, bronchitis, Pneumocystis carinii pneumonia


-Frequency not reported: Pleural effusion, sinus congestion


Retinal detachment has only been reported in AIDS patients treated with this drug for CMV retinitis.

Very common (10% or more): Retinal detachment (up to 15%)

Common (1% to 10%): Blurred vision, macular edema, vitreous floaters, eye pain

Uncommon (0.1% to 1%): Visual disturbance, conjunctivitis


-Frequency not reported: Amblyopia, blindness, eye hemorrhage, eye pain, glaucoma, abnormal vision, vitreous disorder


Very common (10% or more): Hyperkalemia (up to 14%), hypophosphatemia (up to 12%)

Common (1% to 10%): Anorexia, cachexia, hypokalemia, hypomagnesemia, hyperglycemia, decreased appetite, dehydration, hypocalcemia, increased blood alkaline phosphatase


-Frequency not reported: Increased blood alkaline phosphatase, decreased blood glucose, increased blood lactic dehydrogenase, decreased blood magnesium, diabetes mellitus, hypocalcemia, hypokalemia, hypoproteinemia


Common (1% to 10%): Abnormal hepatic function (including severe), increased AST

Uncommon (0.1% to 1%): Increased ALT


-Frequency not reported: Hepatitis, jaundice, abnormal hepatic function


Uncommon (0.1% to 1%): Anaphylactic reaction

Frequency not reported: Valganciclovir hypersensitivity

Postmarketing reports: Anaphylaxis

Editorial References and Review

Medically reviewed by USARx EDITORIAL TEAM Last updated on 1/27/2021.

Source: Drugs.com Valganciclovir (www.drugs.com/mtm/valganciclovir.html).